Skip to main content
Clinical Trials/NCT05653804
NCT05653804Active, not recruitingNot Applicable

Impact of Tele-visit Versus Home Visit by Home Care Provider on Compliance With Continuous Positive Airway Pressure (CPAP) Therapy of Patients With Obstructive Sleep Apnea Syndrome

AGIR à Dom1 site in 1 country320 target enrollmentStarted: April 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
320
Locations
1
Primary Endpoint
To compare CPAP compliance between the two management modalities

Study Overview

Brief Summary

To determine the impact of telecare on continous positive airway pressure (CPAP) patients follow up by home care provider (HCP)

Detailed Description

Obstructive sleep apnea (OSA) syndrome is a chronic respiratory pathology affecting 4% of french adult population and reference treatment for moderate to severe forms of obstructive sleep apnea syndrome (OSA) is continuous positive airway pressure (CPAP).

However, CPAP treatment is binding, so nearly a quarter of patients abandoning treatment at 1 year and nearly half of them at 3 years. Support for these patients on CPAP must therefore be optimal and seek patient satisfaction; HCP (Home Care Provider) plays an important role in this follow-up.

Since 2018 in France, teleconsultation entered on common law but was little used. The pandemic has disrupted the habits of care and patients monitoring by developing remote monitoring. Home Care Providers (HCP) have also been forced to organize remote monitoring, particularly for the annual follow-up visit (technical tele-visit).

The impact of the annual follow-up visits of HCP by tele-visit has never been clinically evaluated. If its clinical relevance were demonstrated and patient satisfaction confirmed, this follow-up modality could become, like telecare, a new standard for the follow-up of patients on CPAP.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age ≥ 18 years
  • •CPAP ≥ 12 months and annual followed by "AGIR à dom" health care provider.
  • •Compliance with CPAP ≥ 4h/night and AHI ≤ 5 events/hour on machine report for the 3 months prior to inclusion

Exclusion Criteria

  • •Follow-up by AGIR à dom. for an other service than package F9.1 : CPAP follow-up and remote monitoring
  • •Unacceptable level of mask leakage
  • •Patient unavailable or willing to move within the next 12 months to an area not covered by AGIR à dom.
  • •Patient considered by the investigator to be unfit for a tele-visit

Arms & Interventions

home visit by HCP

No Intervention

Standard care : patients receive an annual CPAP home visit by HCP technician

tele-visit by HCP

Experimental

Patients receive a annual CPAP remote visit by HCP technician, then home visit the following year

Intervention: tele-visit (Procedure)

Outcomes

Primary Outcomes

To compare CPAP compliance between the two management modalities

Time Frame: Over the 3 months (tele)visit follow-up

CPAP mean compliance between intervention and control groups, adjusted for the three months prior to inclusion : in hours/day, collected on the CPAP remote monitoring report

Secondary Outcomes

  • To compare treatment quality on mask leakage between the two management modalities(Over the 3 months (tele)visit follow-up)
  • To compare occurrence frequency of CPAP-related adverse effect(s) between the two management modalities(Over the 3 months (tele)visit follow-up)
  • To compare impact on quality of life between the two management modalities(At 3 months after (tele-)visit follow-up)
  • To compare follow-up impact in addition to the annual visit between the two management modalities(Over the 12 months (tele)visit follow-up)
  • To compare overall patient satisfaction between the two management modalities(Immediately after the (tele-)visit follow-up)
  • To compare impact on CPAP continuation between the two management modalities(Over the 12 months (tele)visit follow-up)
  • To compare treatment effectiveness between the two management modalities(Over the 12 months (tele)visit follow-up)
  • To evaluate failed visits number between the two care modalities(Over the 12 months (tele)visit follow-up)
  • To evaluate technician satisfaction with tele-visits(Immediately after the (tele-)visit follow-up)
  • To compare the impact on daytime sleepiness between the two management modalities(At 3 months after (tele-)visit follow-up)
  • To compare CPAP compliance in medium term between the two management modalities(Over the 12 months (tele)visit follow-up)
  • To evaluate patient satisfaction with tele-visits(Immediately after the (tele-)visit follow-up)
  • Comparison of the environmental impact associated with the two patient follow-up methods (home visit versus tele-visit)(Over the 12 months (tele)visit follow-up)

Investigators

Sponsor
AGIR à Dom
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials